Trials / Unknown
UnknownNCT03096496
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
Long-term Quality of Life Symptom Burden in Acute Promyelocytic Leukemia (APL) Patients Treated With Arsenic Trioxide (ATO) or Standard Chemotherapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 161 (estimated)
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective and international observational study run by the GIMEMA. All data will be centrally collected and analyzed at the GIMEMA Data Center in Rome (Italy). Patients reported outcomes will be collected using internationally validated questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | QoL questionnaires | Quality of life questionnaires |
Timeline
- Start date
- 2017-03-27
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
- First posted
- 2017-03-30
- Last updated
- 2021-02-08
Locations
16 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03096496. Inclusion in this directory is not an endorsement.